Funds holding Immunocore Holdings PLC
ISIN US45258D1054 · United States · LEI 213800IUE3DFS84BVN18
- Fund holders
- 67
- Of which ETFs
- 12 55 other funds
- Value held
- ≈ 433.6M $ 433.6M $ · 18.3K €
- Share of capital
- 28.4 % of 51.5M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 4,246,274 | 118.5M $ | 0.32 % | 8.25 % | as of Apr 30, 2026 ↗ |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 2,425,650 | 73.1M $ | 0.30 % | 4.71 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,179,792 | 38.1M $ | 0.05 % | 2.29 % | as of Feb 28, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 1,112,800 | 31.1M $ | 0.46 % | 2.16 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 643,368 | 19.4M $ | 0.18 % | 1.25 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 500,000 | 16.2M $ | 0.26 % | 0.97 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 465,030 | 14M $ | 0.17 % | 0.90 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 351,286 | 11.3M $ | 0.05 % | 0.68 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 321,500 | 10.4M $ | 0.19 % | 0.62 % | as of Feb 28, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 304,295 | 9.8M $ | 0.47 % | 0.59 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 296,284 | 8.9M $ | 0.10 % | 0.58 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 291,070 | 9.4M $ | 0.04 % | 0.57 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 277,185 | 8.4M $ | 0.10 % | 0.54 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 264,520 | 8M $ | 0.18 % | 0.51 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 260,000 | 7.3M $ | 0.25 % | 0.50 % | as of Apr 30, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 227,200 | 6.3M $ | 0.30 % | 0.44 % | as of Apr 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 188,691 | 6.1M $ | 0.09 % | 0.37 % | as of Feb 27, 2026 ↗ |
| Fidelity Capital Appreciation Fund Fidelity Capital Trust | 158,900 | 4.4M $ | 0.06 % | 0.31 % | as of Apr 30, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 108,668 | 3M $ | 0.42 % | 0.21 % | as of Apr 30, 2026 ↗ |
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 102,016 | 3.1M $ | 0.43 % | 0.20 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 84,000 | 2.5M $ | 0.25 % | 0.16 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS | 63,806 | 1.9M $ | 0.01 % | 0.12 % | as of Mar 31, 2026 ↗ |
| HUSSMAN STRATEGIC MARKET CYCLE FUND Hussman Investment Trust | 60,000 | 1.8M $ | 0.46 % | 0.12 % | as of Mar 31, 2026 ↗ |
| VANGUARD INTERNATIONAL EXPLORER FUND VANGUARD WHITEHALL FUNDS | 55,192 | 1.5M $ | 0.10 % | 0.11 % | as of Apr 30, 2026 ↗ |
| NYLI Fiera SMID Growth Fund NEW YORK LIFE INVESTMENTS FUNDS TRUST | 53,781 | 1.5M $ | 0.65 % | 0.10 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 45,035 | 1.5M $ | 1.05 % | 0.09 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 39,016 | 1.2M $ | 0.18 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 35,726 | 997.1K $ | 0.33 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Old Westbury Small & Mid Cap Strategies Fund Old Westbury Funds Inc | 35,496 | 990.7K $ | 0.01 % | 0.07 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 33,934 | 1M $ | 0.13 % | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 33,089 | 1.1M $ | 0.03 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 28,275 | 913.3K $ | 0.57 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 26,553 | 800.6K $ | 0.14 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 25,714 | 717.7K $ | 1.21 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 25,502 | 823.7K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Large-Cap Growth Portfolio PACIFIC SELECT FUND | 25,052 | 755.3K $ | 0.06 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND Voya Mutual Funds | 22,848 | 637.7K $ | 0.11 % | 0.04 % | as of Apr 30, 2026 ↗ |
| SmallCap Account Principal Variable Contract Funds, Inc | 20,500 | 618.1K $ | 0.36 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 17,356 | 560.6K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Nationwide International Small Cap Fund Nationwide Mutual Funds | 16,642 | 464.5K $ | 0.16 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 16,454 | 496.1K $ | 0.22 % | 0.03 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 13,700 | 413.1K $ | 0.24 % | 0.03 % | as of Mar 31, 2026 ↗ |
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 12,125 | 365.6K $ | 0.35 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 11,527 | 347.5K $ | 0.22 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 11,435 | 344.8K $ | 0.10 % | 0.02 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 11,423 | 369K $ | 0.02 % | 0.02 % | as of Feb 28, 2026 ↗ |
| International Opportunities Fund VALIC Co I | 10,104 | 326.4K $ | 0.09 % | 0.02 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 7,351 | 237.4K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Empower Small Cap Growth Fund EMPOWER FUNDS, INC. | 5,912 | 178.2K $ | 0.08 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Company Value Trust John Hancock Variable Insurance Trust | 5,890 | 177.6K $ | 0.14 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Dynamic Capital Appreciation Portfolio Variable Insurance Products Fund III | 5,700 | 171.9K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 5,130 | 154.7K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4,500 | 135.7K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 3,458 | 96.5K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 3,314 | 99.9K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| HUSSMAN STRATEGIC ALLOCATION FUND Hussman Investment Trust | 3,000 | 90.5K $ | 0.35 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 2,468 | 74.4K $ | 0.37 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,432 | 78.6K $ | 0.10 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,015 | 65.1K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| First Trust Small Cap BuyWrite Income ETF First Trust Exchange-Traded Fund VI | 1,281 | 38.6K $ | 0.17 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF Invesco Exchange-Traded Fund Trust II | 1,088 | 30.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 995 | 27.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 950 | 28.6K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 730 | 22K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 537 | 16.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 449 | 13.5K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 18.3K € | 0.50 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Etf ETFis Series Trust I | 1.21 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.05 % | as of Feb 28, 2026 ↗ |
| NYLI Fiera SMID Growth Fund NEW YORK LIFE INVESTMENTS FUNDS TRUST | 0.65 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 0.57 % | as of Feb 28, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 0.50 % | as of Dec 31, 2025 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 0.47 % | as of Feb 28, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 0.46 % | as of Apr 30, 2026 ↗ |
| HUSSMAN STRATEGIC MARKET CYCLE FUND Hussman Investment Trust | 0.46 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 0.43 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 0.42 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 66 | +7 | 14,616,014 | -11.8 % |
| 2026Q1 | 59 | +2 | 16,568,566 | -2.0 % |
| 2025Q4 | 57 | -5 | 16,912,490 | -2.1 % |
| 2025Q3 | 62 | -3 | 17,269,901 | -1.7 % |
| 2025Q2 | 65 | -9 | 17,572,278 | -2.2 % |
| 2025Q1 | 74 | -10 | 17,959,342 | +0.3 % |
| 2024Q4 | 84 | -23 | 17,903,054 | +19.6 % |
| 2024Q3 | 107 | -9 | 14,963,419 | +30.8 % |
| 2024Q2 | 116 | +17 | 11,439,156 | +87.3 % |
| 2024Q1 | 99 | +1 | 6,106,405 | -19.8 % |
| 2023Q4 | 98 | 7,614,002 |
Institutional managers
141 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| RTW INVESTMENTS, LP | 4,869,798 | 146.8M $ | as of Mar 31, 2026 |
| FMR LLC | 4,829,154 | 145.6M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 4,706,168 | 141.9M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 3,693,241 | 111.4M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 2,796,803 | 84.3M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,766,868 | 83.4M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 2,649,368 | 79.9M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,931,884 | 58.2M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,891,600 | 57K $ | as of Mar 31, 2026 |
| Logos Global Management LP | 1,500,000 | 45.2M $ | as of Mar 31, 2026 |
| BVF INC/IL | 1,294,463 | 39M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,237,403 | 37.3M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,188,000 | 35.8M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,102,271 | 33.2M $ | as of Mar 31, 2026 |
| Fiera Capital Corp | 1,080,099 | 32.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,021,265 | 30.8M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 919,332 | 27.7K $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 884,937 | 26.7M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 734,397 | 22.1M $ | as of Mar 31, 2026 |
| Trails Edge Capital Partners, LP | 682,597 | 20.6M $ | as of Mar 31, 2026 |
| Caption Management, LLC | 661,786 | 20M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 656,309 | 19.8M $ | as of Mar 31, 2026 |
| Hudson Bay Capital Management LP | 633,174 | 19.1M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 594,712 | 17.9M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 519,130 | 15.7M $ | as of Mar 31, 2026 |
Declared shareholders of Immunocore Holdings PLC
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vestal Point Capital, LP and 1 other | 5.50 % | 2,766,868 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Investment Management, Inc. | 3.70 % | 1,891,600 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Immunocore Holdings PLC
15 funds declare 15 bond lines of this company. The amount is the one filed, never a share of the debt: no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Franklin Convertible Securities Fund | 1 | 17.9M $ | as of Apr 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 1 | 13.9M $ | as of Mar 31, 2026 |
| iShares Convertible Bond ETF | 1 | 5.7M $ | as of Apr 30, 2026 |
| State Street(R) SPDR(R) Bloomberg Convertible Securities ETF | 1 | 4.5M $ | as of Mar 31, 2026 |
| THE HARTFORD STRATEGIC INCOME FUND | 1 | 3.9M $ | as of Apr 30, 2026 |
| Miller Market Neutral Income Fund | 1 | 2M $ | as of Apr 30, 2026 |
| T. Rowe Price Health Sciences Portfolio | 1 | 666.2K $ | as of Mar 31, 2026 |
| Mercer Opportunistic Fixed Income Fund | 1 | 518.6K $ | as of Mar 31, 2026 |
| T. Rowe Price Dynamic Credit Fund | 1 | 498.6K $ | as of Mar 31, 2026 |
| Hartford Multi-Asset Income Fund | 1 | 342.7K $ | as of Apr 30, 2026 |
| THE HARTFORD INFLATION PLUS FUND | 1 | 249.2K $ | as of Apr 30, 2026 |
| Hartford Strategic Income ETF | 1 | 248.3K $ | as of Apr 30, 2026 |
| Multi-Asset Strategy Fund | 1 | 84.8K $ | as of Apr 30, 2026 |
| 1290 VT Convertible Securities Portfolio | 1 | 62.8K $ | as of Mar 31, 2026 |
| Multi-Strategy Income Fund | 1 | 51.8K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Funds holding Immunocore Holdings PLC". https://titelia.com/en/stocks/immunocore-holdings-plc-US45258D1054